The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.
T. Rowe Price International Eq Index PIEQX
- NAV / 1-Day Return 16.69 / +1.15 %
- Total Assets 744.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.260%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 2.85%
- Turnover 29%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:16 PM GMT+0
Morningstar’s Analysis PIEQX
Will PIEQX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.83 | 27.6 Mil | Healthcare |
ASML Holding NV | 2.48 | 24.1 Mil | Technology |
Nestle SA | 1.64 | 15.9 Mil | Consumer Defensive |
AstraZeneca PLC | 1.45 | 14.1 Mil | Healthcare |
Shell PLC | 1.39 | 13.5 Mil | Energy |
Toyota Motor Corp | 1.31 | 12.7 Mil | Consumer Cyclical |
SAP SE | 1.27 | 12.4 Mil | Technology |
Lvmh Moet Hennessy Louis Vuitton SE | 1.27 | 12.3 Mil | Consumer Cyclical |
Novartis AG Registered Shares | 1.26 | 12.3 Mil | Healthcare |
Msci Eafe Fut 9/24 | 1.24 | 12.1 Mil | — |